01-01-1970 12:00 AM | Source: Reuters
Novartis fourth-quarter sales, core net income trail analyst expectations
ZURICH - Novartis's fourth-quarter sales and profit rose less than analysts expected, as the Swiss drugmaker said on Tuesday that the COVID-19 pandemic affected divisions including opthalmology, dermatology and its generics unit.
Core net income in the final three months of 2020 rose 3% in constant currencies to $3.03 billion, compared to the average forecast of $3.15 billion in a Refinitiv poll of analysts. Sales rose 1% to $12.77 billion, compared to $12.88 billion forecast in the poll.
Latest News
Nifty closed below its 5-day moving average support ...
FM Nirmala Sitharaman set to present her 7th Budget,...
Daily Commodity Market Outlook 23.07.2024 by Mr. An...
Market is expected to open on a flattish note and li...
What small traders from Varanasi expect from the Uni...
Sell Kapas Apr @ 1625 SL 1640 TGT 1605-1590. NCDEX -...
Banking index is likely to trade in line with the be...
Economic Survey: Non-farm sectors to play important ...
Pre-Market comment by Deven Mehata , Research Analys...
Opening Bell : Markets likely to get cautious start ...